Screening for autosomal recessive and X-linked conditions during pregnancy and preconception: a practice resource of the American College of Medical Genetics and Genomics (ACMG)
41436_2021_1203_OnlinePDF
Learn More
Focused Revision: Policy statement on folic acid and neural tube defects
s41436-021-01226-6
Learn More
ACMG Publishes its First Evidence-based Clinical Guideline
Evidence-based Clinical Guideline Exome and Genome Sequencing final 7.1
Learn More
Direct-to-consumer prenatal testing for multigenic or polygenic disorders: a position statement of the American College of Medical Genetics and Genomics (ACMG)
s41436-021-01247-1
Learn More
Genetic testing for inherited colorectal cancer and polyposis, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG) (update of Hegde et al. 2013)
colorectal-cancer-revision
Learn More
Chromosomal microarray analysis, including constitutional and neoplastic disease applications, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG) (update of Cooley et al. 2013, South et al. 2013)
chromosomal-microarray-analysis
Learn More
Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and Genomics (ACMG)
41436_2021_1171_OnlinePDF-1
Learn More
ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG)
41436_2021_1172_OnlinePDF-1
Learn More
Management of individuals with germline variants in PALB2: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)
41436_2021_1151_OnlinePDF
Learn More
Next-generation sequencing for constitutional variants in the clinical laboratory, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG) (update of Rehm et al. 2013)
s41436-021-01139-4
Learn More